No abstract available
Keywords:
1,5-anhydroglucitol; GlycoMark®; canagliflozin; sodium-glucose cotransporter 2 inhibitor.
Publication types
-
Clinical Trial, Phase III
-
Letter
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Blood Glucose / analysis
-
Canagliflozin
-
Deoxyglucose / blood*
-
Diabetes Mellitus, Type 2 / blood
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Double-Blind Method
-
Follow-Up Studies
-
Glucosides / therapeutic use*
-
Glycated Hemoglobin / analysis
-
Humans
-
Prognosis
-
Sodium-Glucose Transporter 2 Inhibitors*
-
Thiophenes / therapeutic use*
Substances
-
Blood Glucose
-
Glucosides
-
Glycated Hemoglobin A
-
Sodium-Glucose Transporter 2 Inhibitors
-
Thiophenes
-
Canagliflozin
-
1,5-anhydroglucitol
-
Deoxyglucose